1. A case of genotype‐3b hepatitis C virus in which the whole genome was successfully analyzed using third‐generation nanopore sequencing. Issue 9 (13th June 2019) Authors: Uchida, Yoshihito; Kouyama, Jun‐ichi; Naiki, Kayoko; Uemura, Hayato; Tsuji, Shohei; Sugawara, Kayoko; Nakao, Masamitsu; Motoya, Daisuke; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 49:Issue 9(2019) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct‐acting antivirals. Issue 3 (25th September 2017) Authors: Kurata, Hayato; Uchida, Yoshihito; Kouyama, Jun‐Ichi; Naiki, Kayoko; Nakazawa, Manabu; Ando, Satsuki; Nakao, Masamitsu; Motoya, Daisuke; Sugawara, Kayoko; Inao, Mie; Imai, Yukinori; Nakayama, Nobuaki; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 48:Issue 3(2018) Page Start: E372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Deteriorated outcome of recent patients with acute liver failure and late‐onset hepatic failure caused by infection with hepatitis A virus: A subanalysis of patients seen between 1998 and 2015 and enrolled in nationwide surveys in Japan. Issue 8 (29th May 2019) Authors: Nakao, Masamitsu; Nakayama, Nobuaki; Uchida, Yoshihito; Tomiya, Tomoaki; Oketani, Makoto; Ido, Akio; Tsubouchi, Hirohito; Takikawa, Hajime; Mochida, Satoshi Journal: Hepatology research Issue: Volume 49:Issue 8(2019) Page Start: 844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis. Issue 11 (26th September 2020) Authors: Uchida, Yoshihito; Tsuji, Shohei; Uemura, Hayato; Kouyama, Jun‐ichi; Naiki, Kayoko; Sugawara, Kayoko; Nakao, Masamitsu; Inao, Mie; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 50:Issue 11(2020) Page Start: 1264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis. Issue 12 (21st September 2020) Authors: Uchida, Yoshihito; Inao, Mie; Tsuji, Shohei; Uemura, Hayato; Kouyama, Jun‐ichi; Naiki, Kayoko; Sugawara, Kayoko; Nakao, Masamitsu; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 50:Issue 12(2020) Page Start: 1355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus. Issue 4 (13th January 2020) Authors: Tsuji, Shohei; Uchida, Yoshihito; Uemura, Hayato; Kouyama, Jun‐Ichi; Naiki, Kayoko; Nakao, Masamitsu; Motoya, Daisuke; Sugawara, Kayoko; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 50:Issue 4(2020) Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Retreatment with sofosbuvir/ledipasvir with or without lead‐in interferon‐β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy. Issue 4 (20th October 2017) Authors: Uemura, Hayato; Uchida, Yoshihito; Kouyama, Jun‐ichi; Naiki, Kayoko; Yamaba, Shinpei; Fuchigami, Akira; Saito, Yoichi; Shiokawa, Keisuke; Fujii, Yohei; Uchiya, Hiroshi; Nakazawa, Manabu; Ando, Satsuki; Nakao, Masamitsu; Motoya, Daisuke; Sugawara, Kayoko; Inao, Mie; Imai, Yukinori; Nakayama, Nobua... Journal: Hepatology research Issue: Volume 48:Issue 4(2018) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation. Issue 5 (21st February 2022) Authors: Uchida, Yoshihito; Uemura, Hayato; Tsuji, Shohei; Yamada, Shunsuke; Kouyama, Jun‐ichi; Naiki, Kayoko; Sugawara, Kayoko; Nakao, Masamitsu; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 52:Issue 5(2022) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate. Issue 3 (9th December 2019) Authors: Uchida, Yoshihito; Nakao, Masamitsu; Tsuji, Shohei; Uemura, Hayato; Kouyama, Jun‐ichi; Naiki, Kayoko; Motoya, Daisuke; Sugawara, Kayoko; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Journal of medical virology Issue: Volume 92:Issue 3(2020) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate. Issue 8 (17th April 2020) Authors: Uchida, Yoshihito; Nakao, Masamitsu; Tsuji, Shohei; Uemura, Hayato; Kouyama, Jun‐ichi; Naiki, Kayoko; Motoya, Daisuke; Sugawara, Kayoko; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Journal of medical virology Issue: Volume 92:Issue 8(2020) Page Start: 1370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗